LBi launches digital health shop in US

Share this article:
LBi, a big European indie digital agency network, is opening up a healthcare marketing shop in the US, seeing opportunity in Publicis' increasing domination of the digital health space.
LBi Health will boast a staff of 70 working out of its New York headquarters and handling a roster of clients including Roche, Bayer, Bristol-Myers Squibb, J&J, AstraZeneca, Forest, Genzyme, WebMD, Massachusetts General Hospital and Mount Sinai.
LBi, a big independent network with roots in London and Scandinavia, has around 1,800 employees working out of 26 offices in 16 countries—mostly in Europe, though the company has made inroads into Asia-Pacific and North America in recent years. LBi US formed from a merger of IconNicholson and Special Ops Media two years back. The company has been quietly building up its US healthcare presence for more than a decade, having built the first consumer site for Viagra and seen 80% growth in its healthcare operations for each of the past four years.  
“With each successive wave of growth, we've brought on more resources, and we're now at a scale where it makes sense for us to become our own agency,” said Gregg Fisher, managing director of LBi Health.
Fisher describes the firm's offering as that of a “multichannel healthcare marketing agency with roots in the digital world that set us apart.” The agency will handle consumer-and professional-focused assignments, bringing tech expertise and an ability to partner with other shops. Their motto is “Creating connections that matter between brands and customers.”
Recent work by the firm includes BMS's Fight HIV Your Way contest for Reyataz and Yervoy professional launch.
Share this article:
You must be a registered member of MMM to post a comment.

Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric